SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001453687-22-000109
Filing Date
2022-06-21
Accepted
2022-06-21 16:15:59
Documents
13
Period of Report
2022-06-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K selb-20220621.htm   iXBRL 8-K 40408
2 EX-3.1 exhibit31_charteramendment.htm EX-3.1 7477
  Complete submission text file 0001453687-22-000109.txt   190551

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT selb-20220621.xsd EX-101.SCH 1946
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT selb-20220621_lab.xml EX-101.LAB 25138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT selb-20220621_pre.xml EX-101.PRE 13083
7 EXTRACTED XBRL INSTANCE DOCUMENT selb-20220621_htm.xml XML 11316
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 221028305
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences